Systemic IL-12 administration alters hepatic dendritic cell stimulation capabilities.
The liver is an immunologically unique organ containing tolerogenic dendritic cells (DC) that maintain an immunosuppressive microenvironment. Although systemic IL-12 administration can improve responses to tumors, the effects of IL-12-based treatments on DC, in particular hepatic DC, remain incomple...
Main Authors: | Tim Chan, Timothy C Back, Jeffrey J Subleski, Jonathan M Weiss, John R Ortaldo, Robert H Wiltrout |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3302816?pdf=render |
Similar Items
-
IL10 and IL12B polymorphisms each influence IL-12p70 secretion by dendritic cells in response to LPS
by: Peng, Judy C., et al.
Published: (2006) -
Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis
by: Li Rong, et al.
Published: (2012-01-01) -
Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis.
by: Yumiko Wada, et al.
Published: (2012-01-01) -
Intracerebral administration of Interleukin-12 (IL-12) and IL-18 modifies the course of mouse scrapie
by: Cartoni Claudia, et al.
Published: (2006-12-01) -
Plexin-B2 and Plexin-D1 in dendritic cells: expression and IL-12/IL-23p40 production.
by: Eda K Holl, et al.
Published: (2012-01-01)